Results 131 to 140 of about 421,458 (295)

Shared Sociodemographic Risk Factors for Neurocognitive Dysfunction in Children With Cancer and Blood Disorders

open access: yesPediatric Blood &Cancer, Volume 73, Issue 1, January 2026.
ABSTRACT Background To investigate the role of social determinants of health (SDoH) in neurocognitive functioning among children with acute lymphoblastic leukemia (ALL), central nervous system (CNS) tumors, and sickle cell disease (SCD). Procedure Fifty‐eight child‐caregiver dyads participated.
Claire E. F. Miller   +5 more
wiley   +1 more source

Genotype Differences and Hydroxyurea Utilization Among Adults With Moderate to Severe Sickle Cell Disease

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 46, Issue 1, January 2026.
ABSTRACT Backgrounds Hydroxyurea (HU) remains underutilized in adults with sickle cell disease (SCD) despite proven benefits. Current HU guidelines primarily target sickle cell anemia (SCA), overlooking other genotypes. Objectives This study examined HU utilization patterns across genotypes among adults considered to have moderate to severe SCD ...
Siang‐Hao Cheng   +4 more
wiley   +1 more source

Cerebral blood flow trajectories in paediatric sickle cell anaemia by age, region, and treatment associations

open access: yesBritish Journal of Haematology, Volume 208, Issue 1, Page 367-372, January 2026.
Opposite to the age trend in healthy children, cerebral blood flow increases with age in children with sickle cell anaemia. Early treatment with hydroxyurea (hydroxycarbamide) may help slow this abnormal trend and protect brain functions.
Ping Zou Stinnett   +10 more
wiley   +1 more source

Evaluation on the application of transcranial Doppler (TCD) and electroencephalography (EEG) in patients with vertebrobasilar insufficiency [PDF]

open access: gold, 2020
Changmin Ke   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy